The Rate of Prescribing Gastrointestinal Prophylaxis with Either a Proton Pump Inhibitor Or an H2-Receptor Antagonist in Nova Scotia Seniors Starting Nonsteroidal Anti-Inflammatory Drug Therapy
BACKGROUND: Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used agents that can cause serious gastrointestinal (GI) side effects. For patients at increased risk of NSAID-related GI complications, prophylaxis with either a nonselective NSAID plus gastroprotective agent (GPA) or, alternative...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2010-01-01
|
| Series: | Canadian Journal of Gastroenterology |
| Online Access: | http://dx.doi.org/10.1155/2010/397610 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832552914871123968 |
|---|---|
| author | Bogdan Superceanu Sander Veldhuyzen van Zanten Chris Skedgel Michael Shepherd Ingrid Sketris |
| author_facet | Bogdan Superceanu Sander Veldhuyzen van Zanten Chris Skedgel Michael Shepherd Ingrid Sketris |
| author_sort | Bogdan Superceanu |
| collection | DOAJ |
| description | BACKGROUND: Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used agents that can cause serious gastrointestinal (GI) side effects. For patients at increased risk of NSAID-related GI complications, prophylaxis with either a nonselective NSAID plus gastroprotective agent (GPA) or, alternatively, therapy with a cyclooxygenase-2 selective inhibitor with or without a GPA such as a proton pump inhibitor (PPI), is recommended. |
| format | Article |
| id | doaj-art-5b96bc4677824736adcf355230dab53d |
| institution | Kabale University |
| issn | 0835-7900 |
| language | English |
| publishDate | 2010-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Canadian Journal of Gastroenterology |
| spelling | doaj-art-5b96bc4677824736adcf355230dab53d2025-02-03T05:57:27ZengWileyCanadian Journal of Gastroenterology0835-79002010-01-0124848148810.1155/2010/397610The Rate of Prescribing Gastrointestinal Prophylaxis with Either a Proton Pump Inhibitor Or an H2-Receptor Antagonist in Nova Scotia Seniors Starting Nonsteroidal Anti-Inflammatory Drug TherapyBogdan Superceanu0Sander Veldhuyzen van Zanten1Chris Skedgel2Michael Shepherd3Ingrid Sketris4Faculty of Computer Science, Dalhousie University, Halifax, Nova Scotia, CanadaDivision of Gastroenterology, University of Alberta, Edmonton, Alberta, CanadaDepartment of Medicine, Dalhousie University, Halifax, Nova Scotia, CanadaFaculty of Computer Science, Dalhousie University, Halifax, Nova Scotia, CanadaCollege of Pharmacy, Dalhousie University, Halifax, Nova Scotia, CanadaBACKGROUND: Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used agents that can cause serious gastrointestinal (GI) side effects. For patients at increased risk of NSAID-related GI complications, prophylaxis with either a nonselective NSAID plus gastroprotective agent (GPA) or, alternatively, therapy with a cyclooxygenase-2 selective inhibitor with or without a GPA such as a proton pump inhibitor (PPI), is recommended.http://dx.doi.org/10.1155/2010/397610 |
| spellingShingle | Bogdan Superceanu Sander Veldhuyzen van Zanten Chris Skedgel Michael Shepherd Ingrid Sketris The Rate of Prescribing Gastrointestinal Prophylaxis with Either a Proton Pump Inhibitor Or an H2-Receptor Antagonist in Nova Scotia Seniors Starting Nonsteroidal Anti-Inflammatory Drug Therapy Canadian Journal of Gastroenterology |
| title | The Rate of Prescribing Gastrointestinal Prophylaxis with Either a Proton Pump Inhibitor Or an H2-Receptor Antagonist in Nova Scotia Seniors Starting Nonsteroidal Anti-Inflammatory Drug Therapy |
| title_full | The Rate of Prescribing Gastrointestinal Prophylaxis with Either a Proton Pump Inhibitor Or an H2-Receptor Antagonist in Nova Scotia Seniors Starting Nonsteroidal Anti-Inflammatory Drug Therapy |
| title_fullStr | The Rate of Prescribing Gastrointestinal Prophylaxis with Either a Proton Pump Inhibitor Or an H2-Receptor Antagonist in Nova Scotia Seniors Starting Nonsteroidal Anti-Inflammatory Drug Therapy |
| title_full_unstemmed | The Rate of Prescribing Gastrointestinal Prophylaxis with Either a Proton Pump Inhibitor Or an H2-Receptor Antagonist in Nova Scotia Seniors Starting Nonsteroidal Anti-Inflammatory Drug Therapy |
| title_short | The Rate of Prescribing Gastrointestinal Prophylaxis with Either a Proton Pump Inhibitor Or an H2-Receptor Antagonist in Nova Scotia Seniors Starting Nonsteroidal Anti-Inflammatory Drug Therapy |
| title_sort | rate of prescribing gastrointestinal prophylaxis with either a proton pump inhibitor or an h2 receptor antagonist in nova scotia seniors starting nonsteroidal anti inflammatory drug therapy |
| url | http://dx.doi.org/10.1155/2010/397610 |
| work_keys_str_mv | AT bogdansuperceanu therateofprescribinggastrointestinalprophylaxiswitheitheraprotonpumpinhibitororanh2receptorantagonistinnovascotiaseniorsstartingnonsteroidalantiinflammatorydrugtherapy AT sanderveldhuyzenvanzanten therateofprescribinggastrointestinalprophylaxiswitheitheraprotonpumpinhibitororanh2receptorantagonistinnovascotiaseniorsstartingnonsteroidalantiinflammatorydrugtherapy AT chrisskedgel therateofprescribinggastrointestinalprophylaxiswitheitheraprotonpumpinhibitororanh2receptorantagonistinnovascotiaseniorsstartingnonsteroidalantiinflammatorydrugtherapy AT michaelshepherd therateofprescribinggastrointestinalprophylaxiswitheitheraprotonpumpinhibitororanh2receptorantagonistinnovascotiaseniorsstartingnonsteroidalantiinflammatorydrugtherapy AT ingridsketris therateofprescribinggastrointestinalprophylaxiswitheitheraprotonpumpinhibitororanh2receptorantagonistinnovascotiaseniorsstartingnonsteroidalantiinflammatorydrugtherapy AT bogdansuperceanu rateofprescribinggastrointestinalprophylaxiswitheitheraprotonpumpinhibitororanh2receptorantagonistinnovascotiaseniorsstartingnonsteroidalantiinflammatorydrugtherapy AT sanderveldhuyzenvanzanten rateofprescribinggastrointestinalprophylaxiswitheitheraprotonpumpinhibitororanh2receptorantagonistinnovascotiaseniorsstartingnonsteroidalantiinflammatorydrugtherapy AT chrisskedgel rateofprescribinggastrointestinalprophylaxiswitheitheraprotonpumpinhibitororanh2receptorantagonistinnovascotiaseniorsstartingnonsteroidalantiinflammatorydrugtherapy AT michaelshepherd rateofprescribinggastrointestinalprophylaxiswitheitheraprotonpumpinhibitororanh2receptorantagonistinnovascotiaseniorsstartingnonsteroidalantiinflammatorydrugtherapy AT ingridsketris rateofprescribinggastrointestinalprophylaxiswitheitheraprotonpumpinhibitororanh2receptorantagonistinnovascotiaseniorsstartingnonsteroidalantiinflammatorydrugtherapy |